ORG Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$7.44K Buy
11
+2
+22% +$1.36K ﹤0.01% 1096
2025
Q3
$5.75K Buy
9
+7
+350% +$4.25K ﹤0.01% 1097
2025
Q2
$1.08K Buy
2
+1
+100% +$478 ﹤0.01% 1325
2025
Q1
$418 Buy
+1
New +$434 ﹤0.01% 1291
2024
Q2
Sell
-7
Closed -$3.72K 1821
2024
Q1
$3.72K Buy
7
+2
+40% +$1.09K 0.01% 367
2023
Q4
$2.77K Sell
5
-41
-89% -$19.2K ﹤0.01% 922
2023
Q3
$20.1K Sell
46
-5
-10% -$2.49K 0.01% 692
2023
Q2
$25.9K Buy
+51
New +$24.4K ﹤0.01% 820

Other funds holding IDXX

ORG Partners's IDXX Position: Q4 2025 in Review

ORG Partners increased its Idexx Laboratories (IDXX) stake by 22% in Q4 2025, buying an estimated $1.36K and bringing the position to 11 shares worth $7.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

ORG Partners first reported a position in IDXX in Q2 2023 and has held it in 8 quarters since. The position peaked at $25.9K in Q2 2023. 1,385 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • ORG Partners held 11 shares of Idexx Laboratories worth $7.44K as of Q4 2025.
  • ORG Partners bought 2 Idexx Laboratories shares in Q4 2025, an estimated $1.36K.
  • Idexx Laboratories made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1096 holding.
  • ORG Partners first reported a position in Idexx Laboratories in Q2 2023 and has held it in 8 quarters since.
  • ORG Partners's Idexx Laboratories position peaked at $25.9K in Q2 2023.
  • 1,385 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.